Previous research has highlighted the widespread expression of CXCR2 not only in tumor cells but also in various immune cells including granulocytes, monocytes, mast cells, and some natural killer cells, as well as in endothelial and myeloid cells, contributing to tumor growth and vasculature development (12). The gene discussed is CXCR2; the disease is neoplasm.